Oral ibuprofen cost effective in neonates with patent ductus arteriosis

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, access via your institution.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Notes

  1. 1.

    2019/2020 US dollars

Reference

  1. Abushanab D, et al. Cost-effectiveness of Oral Versus Intravenous Ibuprofen Therapy in Preterm Infants With Patent Ductus Arteriosus in the Neonatal Intensive Care Setting: A Cohort-based Study. Clinical Therapeutics : 8 Jan 2021. Available from: URL: http://doi.org/10.1016/j.clinthera.2020.12.004

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Oral ibuprofen cost effective in neonates with patent ductus arteriosis. PharmacoEcon Outcomes News 870, 19 (2021). https://doi.org/10.1007/s40274-021-7422-8

Download citation